EpitalonSleep rhythm, recovery, and longevity interest — done the right way.
A four-amino-acid peptide studied for melatonin rhythm, telomerase activity, and aging.
Epitalon is the short peptide people want when sleep and recovery keep slipping with age. An FDA advisory committee recommended it for compounding in July 2026. Join the waitlist for first access when pharmacy-sourced Epitalon can be evaluated through AlphaMD.
By joining, you opt in to launch and marketing email about Epitalon from AlphaMD. You can unsubscribe at any time.
- U.S. compounding pharmacies only
- Discreet shipping
- 100% confidential
Why Epitalon Gets Attention
Four amino acids from the pineal research tradition.
Epitalon is a synthetic tetrapeptide — alanine, glutamic acid, aspartic acid, and glycine (AEDG). It came out of Soviet-era work at the St. Petersburg Institute of Bioregulation and Gerontology, where researchers studied the pineal gland and its role in circadian rhythm and aging.
One naming distinction matters for claims you will see online. Epitalon is not Epithalamin. Epithalamin is a complex pineal-gland tissue extract; the long-term Russian cohort findings people cite on mortality belong to Epithalamin studies. The FDA treats them as separate substances. This page keeps them separate so you know what you are waitlisting for.
What Epitalon itself has is promising laboratory and animal work: telomerase induction in cultured fibroblasts, melatonin rhythm shifts in aging rhesus monkeys, and lifespan signals in mice. Controlled human sleep trials measuring sleep quality have not been published. In July 2026 an advisory committee recommended compounding inclusion 7–4 with one abstention.
Where Epitalon Stands Today
- Recommended for compoundingAdvisory vote 7–4 (1 abstention), July 24, 2026
- FDA scientists advised against itAgency staff recommended no; the advisory committee voted yes 7–4
- No sleep endpoint measured yetFDA found no insomnia study measuring sleep latency, duration, or quality
- Not an FDA-approved drugNo approved indication, no approved dosing label
- Unsettled in tested sportNot named by WADA, but the S0 catch-all can still reach it
- Prescription-only at launchProvider evaluation and intake required — no direct purchase
Longevity headlines often cite Epithalamin, a different substance. Final compounding for Epitalon still needs FDA rulemaking — the waitlist is first access when that path opens.
What You May Get From Epitalon
The sleep, recovery, and longevity upsides people want — with a clear read on how far the research goes.
Melatonin rhythm
The best-supported claim so far: in aging rhesus monkeys, evening melatonin shifted back toward a younger pattern — closer to human physiology than a mouse study, and still not a human trial.
Animal dataTelomerase activity
Induced telomerase and extended telomeres in cultured human fetal fibroblasts. A cell-culture finding that fuels longevity interest — see risks for why cancer history is a hard stop.
Lab dataSleep quality
The use the FDA reviewed. Human references so far measure melatonin metabolites more than sleep itself — interest is high; sleep-outcome trials are still needed.
Theory onlyLifespan in animals
In mice, mean lifespan did not move while maximum lifespan increased — a curious longevity signal, not a human lifespan claim.
Animal dataAntioxidant and stress-response signaling
Reported across rodent and cell work. Consistent enough to stay interesting for recovery-focused readers; still early as formal proof.
Lab dataWho Epitalon May Be A Fit For
A provider makes this call with you after reviewing your history and labs.
- Living with insomnia that has already been worked up — sleep study done, apnea and depression ruled out or already being treated.
- Interested in aging and recovery research, with clear expectations that most Epitalon data is still preclinical.
- Wanting a provider-led plan rather than running an experiment alone from a research vial.
- Not in cancer treatment or active surveillance — the risks section explains why this filter is unusually specific here.
- Already an AlphaMD member who would rather add something new to a chart someone reviews.
Who Should Skip It
Practical fit filters — a provider will decline when these apply.
- You have an active or recent cancer diagnosis. Telomerase activation is the mechanism Epitalon is best known for, and it is also one of the ways abnormal cells avoid dying on schedule. This is a hard stop.
- You need a sleep evaluation first. Obstructive sleep apnea and depression both present as insomnia — and both have treatments that work.
- You are relying on Epithalamin longevity numbers. Those studies used a pineal-gland extract. Different substance — results do not transfer to synthetic Epitalon.
- You're pregnant, nursing, or trying to conceive. There is no reproductive or developmental toxicology at all.
- You're under 18, or you are unwilling to complete intake and follow-up.
What To Know About Risks
Epitalon has no human safety studies yet, and it carries one theoretical concern specific enough that FDA reviewers wrote it down.
The telomerase and cancer question
Because Epitalon may activate telomerase, FDA raised a theoretical concern that prolonged exposure could help abnormal cells escape senescence. Epitalon has not been shown to cause cancer — and it has also never been studied long enough in humans to rule it out.
No human safety studies yet
No clinical safety trial, no established side-effect list, no dosing range validated in a person. Provider oversight is the plan at launch.
Longer telomeres are not automatically better
Telomere length tracks with aging; it is not a simple "turn up to reverse age" dial. Cells that refuse to retire on schedule are also how several diseases start.
Inconsistent chemical naming
Epitalon, Epithalon, Epithalone, free base, acetate — and Epithalamin, which is something else. Naming inconsistency makes gray-market labels especially hard to trust.
Aggregation and immunogenicity
Peptides can clump during manufacturing and storage, and aggregates are more likely to provoke an immune response.
Gray-market product quality
When even the substance name is ambiguous, pharmacy identity testing becomes the largest controllable variable.
Pharmacy-Sourced Beats Gray-Market Guesswork
Epitalon is sold online under several spellings, sometimes swapped with a pineal extract that is not the same substance, and nearly always "for research use only." Independent testing of gray-market vials keeps finding the same failures.
Gray-market vials
- Peptide content well under — or over — what the label claims
- Bacterial endotoxin from non-sterile production — a fever and sepsis risk you inject directly
- Residual synthesis solvents, heavy metals, and truncated peptide fragments
- Certificates of analysis that are copied, expired, or for an entirely different lot
- No prescriber, no recall path, and no one accountable if you're harmed
A U.S. compounding pharmacy
- State-licensed, FDA-inspected facility working from a real prescription
- Sterile compounding standards for anything injected, with documented process controls
- Third-party potency, sterility, and endotoxin testing tied to your specific lot
- A provider who sets your dose, reviews your labs, and owns follow-up
- Traceability — if a lot is bad, it can be found, pulled, and reported
When Epitalon launches with AlphaMD, members get a pharmacy that can verify what is in the vial — after a provider evaluation.
Educational Resources
Deeper reading on what Epitalon is, how it differs from Epithalamin, and why sourcing decides most of the risk.
Epitalon benefits, risks, and side effects: what you need to know
The long-form deep dive: pineal research, telomerase findings, Epithalamin vs Epitalon, and what the FDA concluded about insomnia.
The FDA reviewed seven popular peptides. Here is what each one may do.
BPC-157, KPV, TB-500, MOTs-c, DSIP, Semax, and Epitalon side by side — reviewed uses, vote counts, and how far the evidence goes.
The peptide quality crisis nobody in the optimization space wants to admit
What third-party testing keeps finding in gray-market vials — and why multi-name substances are hardest to verify.
Frequently Asked Questions
Still deciding? Message the team — you don't need to be a member to ask.
Ask a QuestionFirst access when pharmacy-compounded Epitalon can be offered through AlphaMD — provider evaluation, intake, and product from a U.S. compounding pharmacy with lot-level testing.
In July 2026 an FDA advisory committee recommended Epitalon for the 503A bulk-substances list. Final rulemaking still has to finish. Once a pharmacy AlphaMD trusts can lawfully produce and test it, the waitlist gets the email that week.
Not yet. Nothing on this page is for sale. If a clinic is offering Epitalon today, ask which licensed U.S. pharmacy compounded it and for lot-specific testing.
That is the use people want, and controlled human sleep-outcome trials have not been published yet. The strongest related signal is melatonin rhythm work in aging monkeys. Insomnia still deserves a workup for apnea and other treatable causes first.
Epitalon is a synthetic four-amino-acid peptide. Epithalamin is a complex pineal-gland extract. Long-term Russian mortality studies used Epithalamin and cannot be assigned to the synthetic peptide. The FDA treats them as different substances.
It did in cultured human fetal fibroblasts. Whether it changes telomeres in a living adult has not been measured. Telomere length is a marker of aging, not a simple control dial — and cancer history is a hard stop because of the telomerase mechanism.
Possession is not a criminal matter for individuals, but Epitalon is not an approved drug and selling it for human use is not lawful. The legitimate route is a prescription after provider evaluation, filled by a licensed compounding pharmacy.
No interaction is known. Raising it at your next visit keeps testosterone, labs, sleep history, and anything new in the same chart.
Pricing is not set until a supplier is locked. When it is, it will be published the same way TRT pricing is: one clear number, per month.
Explore Other Peptides
Five more on the same July 2026 compounding slate — join each waitlist for first access when they launch.
Get First Access to Epitalon
Join the waitlist for pharmacy-sourced Epitalon through AlphaMD — provider evaluation, identity-tested product, discreet shipping. Already a member? Bring peptides up at your next visit or book a consult to get intake done early.
By joining, you opt in to launch and marketing email about Epitalon from AlphaMD. You can unsubscribe at any time.
No insurance needed · Cancel anytime · 100% confidential
Legal Disclaimer
Epitalon is not an FDA-approved drug and is not currently available for sale or prescription through AlphaMD. Nothing on this page is an offer to sell, and nothing here is medical advice. Statements about potential benefits describe published preclinical laboratory and animal research on Epitalon, which is a different substance from the pineal extract Epithalamin and are not claims about outcomes for any individual. Peptide therapy, if and when offered, will require a consultation with a licensed medical professional, a completed medical intake, and appropriate laboratory testing; it is not appropriate for everyone. Epitalon is not named on the World Anti-Doping Agency Prohibited List, but the List's non-approved substances class is a catch-all that can still reach substances lacking regulatory approval; athletes subject to testing should confirm status with their anti-doping organization before use.
Medical services are provided by independent, licensed providers through AlphaMD's affiliated professional practices. AlphaMD provides administrative and technology services and does not practice medicine.